DCI Donor Services – FDA 483, Dec 19, 2019
An FDA inspection of DCI Donor Services in West Sacramento, CA, a human tissue establishment, revealed significant deficiencies in donor screening and facility procedures. The firm failed to adequately screen placenta donors for communicable diseases like West Nile Virus and lacked proper written procedures for HCT/P donor eligibility determinations, including for Zika Virus. Additionally, the facility did not follow its established cleaning and decontamination procedures for surgical recovery suites.
ID · 080d97ef-d029-4279-9330-1785b9b6f68c
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.